Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000877092 | SCV001019767 | likely benign | Neuroblastoma, susceptibility to, 3 | 2023-01-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001021474 | SCV001183096 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-12-15 | criteria provided, single submitter | clinical testing | The c.3939-5C>T intronic variant results from a C to T substitution 5 nucleotides upstream from coding exon 27 in the ALK gene. This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |